🟢 Pacific Biosciences is trading 7.1% up with no clear company-specific catalyst identified

Pacific Biosciences is trading at $1.74, up 7.10%, with no clear company-specific explanation for its September 28 rise identified in the search.

• Recent coverage of cost savings and sequencing strategy predates the session and does not establish a cause.
• Broader markets are under pressure amid rising oil prices, Treasury yields and renewed U.S.-Iran tensions. Pacific Biosciences is moving against the market, but this context does not explain its gain.